Olivia Orozco - Concepedia

Author

Olivia Orozco

Biogen (United States)

Also Known As

Olivia E. Orozco, Olivia Orozco

Publications

914

Citations

H-Index

Concepts

All Affiliations

Biogen (United States)Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"National Cancer Institute

About

Olivia Orozco is an author at Biogen (United States) specializing in medicine, cancer research, and developmental biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	599
2	Cell Biology	3	3	372
3	Cellular Physiology	2	2	299
4	Social Sciences	1	1	156
5	Biology	1	1	267

Olivia Orozco

Publications

858

Citations

H-Index

Page 1

	Year	Citations
Expression of Radical fringe in limb-bud ectoderm regulates apical ectodermal ridge formation Ed Laufer, Randall D. Dahn, Olivia Orozco, Nature BiologySkin DevelopmentDevelopmental BiologyTissue DevelopmentRadical Fringe	1997	267
GFRalpha3 is expressed predominantly in nociceptive sensory neurons Olivia Orozco, Lee Walus, Dinah W.Y. Sah, European Journal of Neuroscience Gfralpha3 ExpressionNeuropathic PainMolecular PainGfralpha3 Artemin NeuronsSocial Sciences	2001	156
Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo Heather B. Adkins, Caterina Bianco, Susan G. Schiffer, Journal of Clinical Investigation	2003	155
Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma Christian Wechselberger, Luigi Strizzi, Nicholas Kenney, Oncogene Tumor BiologyDevelopmental BiologyMedicineMammary GlandPathology	2005	73
An antibody–cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours Rebecca K. Kelly, Dian L. Olson, Yaping Sun, European Journal of Cancer Antibody–cytotoxic ConjugateCripto Positive TumoursMedicineNew Targeted TherapyImmunology	2011	42
Glial Cell Line-Derived Neurotrophic Factor (GDNF) Receptor α-1 (GFRα1) Is Highly Selective for GDNF versus Artemin Paul Carmillo, Lone Dagø, Eric S. Day, Biochemistry	2005	39
Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid Tumors Alexander M. Taylor, Bret R. Williams, Fabrizio Giordanetto, Journal of Medicinal Chemistry	2023	37
Perturbation of RET signaling in the embryonic kidney Christian W. Ehrenfels, Paul Carmillo, Olivia Orozco, Developmental Genetics Ld GenesNephrologyRet-ig Fusion ProteinCellular PhysiologyEmbryology	1999	32
CRIPTO3, a presumed pseudogene, is expressed in cancer Chao Sun, Olivia Orozco, Dian L. Olson, Biochemical and Biophysical Research Communications Tumor BiologyMedicinePathologyCancer GeneticsCancer Biology	2008	29
Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies Lawrence L’Italien, Olivia Orozco, Tinya J. Abrams, Clinical Cancer Research	2018	28

Page 1